Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cold Spring Harbor Perspectives in Medicine|October 3, 2014
Therapeutic strategies to inhibit MYCMichael R McKeown, James E BradnerNature Methods|May 6, 2008
Improving the photostability of bright monomeric orange and red fluorescent proteinsNathan C Shaner, Michael Z Lin, Michael R McKeown, et al.Cell|August 21, 2012
Small-molecule inhibition of BRDT for male contraceptionMartin M Matzuk, Michael R McKeown, Panagis Filippakopoulos, et al.Chemistry & Biology|November 28, 2009
Autofluorescent proteins with excitation in the optical window for intravital imaging in mammalsMichael Z Lin, Michael R McKeown, Ho-Leung Ng, et al.Nature Methods|September 11, 2012
Improving FRET dynamic range with bright green and red fluorescent proteinsAmy J Lam, François St-Pierre, Yiyang Gong, et al.Journal of Medicinal Chemistry|October 15, 2014
Biased multicomponent reactions to develop novel bromodomain inhibitorsMichael R McKeown, Daniel L Shaw, Harry Fu, et al.Cancer Discovery|July 22, 2017
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα AgonistMichael R McKeown, M Ryan Corces, Matthew L Eaton, et al.Cancer Cell|December 17, 2013
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphomaBjoern Chapuy, Michael R McKeown, Charles Y Lin, et al.Journal of Medicinal Chemistry|November 15, 2023
Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent CancersDavid B Freeman, Tamara D Hopkins, Peter J Mikochik, et al.Cancer Research|November 17, 2025
Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple MyelomaW Frank Lenoir, Michael R McKeown, Giulia Giorgetti, et al.Pageof 2